The pharmaceutical industry wants to do the right thing and address health equity. But figuring out what to do first is proving to be a challenge. Tony Gibson, a Principal at Valuate Health, shares his thoughts on how pharma can meaningfully address health equity.
Health equity is a big topic in the pharmaceutical industry right now, but the topic is so large that manufacturers don't know where to start. Tony Gibson, MHA, a Principal at Valuate Health, has some advice on how pharma can address health equity in a meaningful way.
Manufacturers have shown a “tremendous willingness to incorporate the voice of the patient,” Gibson says. But their health equity messaging tends to be the weak link. “It can come off as window dressing which minimizes this very important topic and reduces it to a catch phrase,” he says.
Gibson recently contributed to a white paper on health equity and pharma.